Institutes, Divisions & Centers
Pulmonary Medicine

Leading the Way in Pediatric Lung Disease Research

The Division of Pulmonary Medicine at Cincinnati Children’s houses research programs that both build upon and expand leading-edge basic, translational and clinical science—ultimately improving outcomes for patients with lung disease. As part of the No. 2-ranked Pulmonary Program in the nation, we lead the pulmonary field in education and training, while maintaining our strong culture of discovery, innovation, compassion and clinical care.

Expert Research Faculty

Our extensive pulmonary research team, comprised of 10 faculty research labs, includes PhDs, MDs and MD/PhDs. Together, we focus on a broad spectrum of lung disease—from more common disorders like asthma to rare lung diseases like interstitial lung disease (ILD).

We also prioritize mentorship, with continued research opportunities for graduate students, post docs, clinical and research fellows, and former trainees.

Robust Funding for Increased Impact

Our research would not be possible without robust funding from the National Institutes of Health, Cystic Fibrosis Foundation and other donors. We have a well-supported wet laboratory and clinical trial infrastructure. And collaborations with outside partners—including the Clinical Trial Consortium, Xenon Clinical Trials Consortium and Bronchopulmonary Dysplasia (BPD) Collaborative—enable us to expand the research in our field even further.

Our Research

For over 20 years, our division has conducted groundbreaking, scientifically diverse research from areas such as cellular and molecular research and translational imaging.

Statistics at a Glance

Research and Training

  • Faculty: 37
  • Joint Appointment Faculty: 11
  • Research Graduate Students: 13
  • Research Fellows and Post Docs: 8

Clinical Activities and Training

  • Clinical Fellows: 12
  • Inpatient Encounters: 13,844
  • Outpatient Encounters: 28,843

Our pulmonary disease centers focus on research in clinical medicine:

We’ve developed world-class MRI technology that shows detailed images of the lungs, heart and airway—even in premature infants. With this imaging, we can better understand conditions like BPD. Combined with basic science research, we’re working to pinpoint the origins of pulmonary disease and find more precise and effective therapies.

Additionally, we’ve created a new airway assessment tool with computational fluid dynamics (CFD) and phase-contrast magnetic resonance imaging (PC-MRI) that could significantly improve care for obstructive sleep apnea.

Research By the Numbers

Each year, our division succeeds in publishing important findings in dozens of top journals, with faculty presenting their work at national and international conferences. 

  • 45+ World-Class Research Experts on Staff
  • $13 Million in Research Funding Per Year
  • 115 Peer-Reviewed Publications in FY23

Pulmonary Medicine Research Publications


View Publications